Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Recurrent and/or Metastatic Esophageal Squamous Cell Carcinoma

Conditions:   Esophageal Cancer, Squamous Cell;   Cetuximab Effect;   Chemotherapy Effect
Interventions:   Drug: cetuximab;   Drug: cisplatin plus paclitaxel
Sponsor:   Peking University
Recruiting - verified April 2017

http://ift.tt/2pWwDkq